Recurrent SMARCA4 mutations in small cell carcinoma of the ovary. - Wikidata - awgldk - TriplyDB

Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.

Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.

http://www.wikidata.org/entity/Q27852975

about

Genomic/Epigenomic Alterations in Ovarian Carcinoma: Translational Insight into Clinical Practice SWI/SNF chromatin remodeling complexes and cancer Distinct genetic alterations in small cell carcinoma from different anatomic sites CIViC database Pathological bases for a robust application of cancer molecular classification SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers The disparate origins of ovarian cancers: pathogenesis and prevention strategies.Establishment of a Strong Link Between Smoking and Cancer Pathogenesis through DNA Methylation Analysis.High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins Limited evidence that cancer susceptibility regions are preferential targets for somatic mutation In vitro and in vivo therapeutic approach for a small cell carcinoma of the ovary hypercalcaemic type using a SCCOHT-1 cellular model.Beware of immunohistochemistry--report of a cytokeratin-, desmin- and INI-1-negative pelvic desmoplastic small round cell tumor in a 51 year old woman.Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type.Primary rhabdoid tumor of the ovary: When large cells become small cells.Genomic Characterization of Non-Small-Cell Lung Cancer in African Americans by Targeted Massively Parallel Sequencing Intra-Gene DNA Methylation Variability Is a Clinically Independent Prognostic Marker in Women's Cancers.Early-Stage Induction of SWI/SNF Mutations during Esophageal Squamous Cell Carcinogenesis.Neuroendocrine Tumors of the Female Reproductive Tract: A Literature Review Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type c-Met inhibitors attenuate tumor growth of small cell hypercalcemic ovarian carcinoma (SCCOHT) populations.Loss of SMARCA4 Expression Is Both Sensitive and Specific for the Diagnosis of Small Cell Carcinoma of Ovary, Hypercalcemic Type Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT).Ovarian small-cell carcinoma hypercalcemic type successfully treated: a case report and literature review Molecular analyses reveal close similarities between small cell carcinoma of the ovary, hypercalcemic type and atypical teratoid/rhabdoid tumor.Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.Sequencing of 279 cancer genes in ampullary carcinoma reveals trends relating to histologic subtypes and frequent amplification and overexpression of ERBB2 (HER2)Loss of switch/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas.BRCA1/FANCD2/BRG1-Driven DNA Repair Stabilizes the Differentiation State of Human Mammary Epithelial Cells.Genomic alterations in neuroendocrine cancers of the ovary.No small surprise - small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumour.Phenotype and genotype in Nicolaides-Baraitser syndrome.Vulnerabilities of mutant SWI/SNF complexes in cancer.Cancer genomics: why rare is valuable.Categorization of cancer through genomic complexity could guide research and management strategies.Biology and Treatment of Rhabdoid Tumor.Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 cases.SMARCA4 inactivating mutations cause concomitant Coffin-Siris syndrome, microphthalmia and small-cell carcinoma of the ovary hypercalcaemic type The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type.Epigenomic regulation of oncogenesis by chromatin remodeling.SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1(neg)/CK7(pos)/HepPar-1(pos) immunophenotype.

P2860

31c717f6b4bfa3723670a8ef01548d3719195ab5 8fde2c9962e93184b4663d383034e95bf17fa177

P248

Q26740622-3DD61435-45DC-409B-AC4F-CF9FAB061348 Q26998657-AF53167A-9139-42CC-898F-1D8851DAB756 Q27008242-DCE61D14-71DD-40C4-AEDC-BEBF0FD9E1AE Q27612411-CE209CF7-9EFD-4788-B4BC-45654C960126 Q28082201-33478E84-B5A6-493F-BAA1-9A2077B59521 Q28818608-3F0D65FE-DF2B-4F22-9261-019F6388098F Q30240709-101E0BBF-C102-4611-AECB-995CA0343954 Q33687347-057740ED-7CC3-4C50-B67E-82A4B94F3D38 Q34469034-5A2C0A9B-2250-4C22-8A09-4CA5249FEC94 Q34494290-72C06014-92AA-42D9-BCC4-0B07FCC5C2D4 Q34598957-4A22DCDC-911B-42F5-B856-7495D5379B71 Q35145286-E75978BF-6B9C-4AB2-A477-E6008B9BD495 Q35195271-EC3E3754-DDF7-47AA-8BE1-2DD22CE104B0 Q35642038-34F4777B-0F21-4B05-A2D8-8F5A50D6FD13 Q35671373-A9921A2E-F68B-441F-A43B-0CF82682EEFC Q35858677-876CA9FC-1B11-4C1A-BCF4-B4608A1933EC Q35905043-73517A98-1D70-480C-9EE9-1445DCCEF9B8 Q36417766-7BA91831-F700-4142-A500-F73143FDF672 Q36420683-4C687141-93F3-4122-97D0-9A0852A35E0E Q36544653-59CF972A-D2F7-4F89-8112-8F1B8C2CEFA6 Q36576557-185FB508-45A9-4BC7-A2E1-D73E94444203 Q36584643-A0CDAC8D-0186-49C4-89AC-7441D31730F3 Q36697127-9230D70A-9688-469B-B861-BB4AC00503DB Q36738953-A2F0B672-B23F-4FD5-9408-2F6EAD8A5B42 Q36800071-0ED571F9-61B8-43F8-BFFD-8D0AB853ECC5 Q37159937-579E2509-9144-44E7-8E10-B2F9F99C8A18 Q37166723-C50B1C18-AE01-4FD2-BAB2-911523A9482B Q37170604-F4594EF4-E50D-4066-899B-DF413E31C8B0 Q37212060-1B3E090F-53DF-4673-B6BA-B7299B1A8770 Q38206140-9D8F682B-BA05-4071-974F-14C15C22D24E Q38244385-A3C24BDD-C50C-4CB4-9E57-1142A2C3CC72 Q38247363-DF4A65EA-683B-4785-A127-E43744E43D09 Q38353573-9AF785A8-FE8E-43E0-9E4B-CB5C0CBAE98D Q38416477-EB5A0C81-4C8A-4F4E-8FBB-0A652E7F16D9 Q38582867-72A04E9E-EB6B-4976-8EAB-5AEB2EAD15B7 Q38627628-CCD04135-BA27-4125-B982-9211C5371DEE Q38700482-B0F3B3F1-6C31-487B-94BB-477EDCD9F380 Q38706007-27CA9417-37AF-4766-A804-3F3925C6F4EB Q38709544-9509CF16-0641-4E14-A053-5B7F9BB7EC25 Q38757918-2B67F0B2-BEBD-4DF2-8D6D-F662959EAF18

P2860

Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.

http://www.wikidata.org/entity/Q27852975

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.

@ast

Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.

@en

Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.

@nl

type

label

Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.

@ast

Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.

@en

Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.

@nl

prefLabel

Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.

@ast

Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.

@en

Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.

@nl

P1433

Q27852975-A5F00E89-CE2B-4D92-85DD-820F197A0CFE

P1476

Q27852975-F48A2E50-07DC-4F64-9D1B-7B7ABF262B44

P2093

Q27852975-1E7C9893-7C00-42BB-8A8B-7DA103C86A74

Q27852975-33463B6A-EF36-4F34-9DC8-D44E95B2A078

Q27852975-6182C1DE-092D-44D2-A0E2-DFD5C1E58E84

Q27852975-6A261A93-2ADE-4A79-A9F8-378B022E2C9C

Q27852975-6D42E75B-1861-469E-A7CA-A345CE1EA12C

Q27852975-DB1F2774-8D1D-4F0B-9C9E-CD1ACD2CE5DE

Q27852975-F004AE08-532F-4D5C-80F9-7F58DC890D10

P2860

Q27852975-00560EB7-FEBA-49F8-ADF8-B0316C641FA1

Q27852975-0114CA76-D3F3-4EB6-8BEF-6EBBC3467862

Q27852975-15AD803B-33AD-41D5-A134-4186C90AC238

Q27852975-20F8F67D-462F-4E23-BC2C-E2A19FA4B629

Q27852975-2C4CFEC5-DF09-405B-AD97-3DEF01B3B6EC

Q27852975-3F9F5498-8622-45FC-8EAD-F155B1010FF3

Q27852975-469E818F-0739-4C43-8265-535B333BC15D

Q27852975-5FF38622-B92E-4C1B-AA60-B1287DB58F0C

Q27852975-74528E48-8F9F-4425-9FA9-77F4522369EC

Q27852975-7A8F5991-5ABF-4B5E-960A-3017857BA7AA

P2888

Q27852975-FA13AA51-F712-4928-B50D-86EB450746EF

P304

Q27852975-643E3456-7F8A-4A1D-9931-8A31D453B5E8

P31

Q27852975-188A419D-9AD3-4438-9412-3A439036C4A2

P3181

Q27852975-EE70EE10-4311-4B82-9F3C-2B40806651EA

P356

Q27852975-D45AE60C-8B38-4034-AFD1-ED6867725D0E

P407

Q27852975-E3122702-9ADD-4E38-907B-00A912FE7E9F

P433

Q27852975-E39DC894-6498-4821-BD8A-A5E62B812617

P478

Q27852975-C4A57C60-7C27-491D-8CFA-BB0D86255FE0

P50

Q27852975-0470AE5A-2E61-4CF5-836A-D95170718CFE

Q27852975-1C4FA4E3-0DD6-4CAA-A2BE-FCE0925A7924

Q27852975-58593988-92B9-4CB0-A357-B1C7A9A42EEC

Q27852975-DC689B98-8379-47ED-B141-0829AAE13021

Q27852975-EF5CBA9B-279F-4E13-93A1-7E941F7837B3

P577

Q27852975-4DB7D456-D409-439F-98C9-50D034A30769

P6179

Q27852975-8163F7B9-DA6F-4C90-88A8-E28A60D7A889

P698

Q27852975-12870DC9-AE87-4830-B662-91EB0D0E3447

P932

Q27852975-44F8F1AB-DD1A-494C-B0D3-486471BF79AC

P3181

P356

P1433

Nature Genetics

P1476

Recurrent SMARCA4 mutations in small cell carcinoma of the ovary

@en

P2093

Fanny Dao

http://www.w3.org/2001/XMLSchema#string

JianJiong Gao

http://www.w3.org/2001/XMLSchema#string

Michael F Berger

http://www.w3.org/2001/XMLSchema#string

Mithat Gonen

http://www.w3.org/2001/XMLSchema#string

Narciso Olvera

http://www.w3.org/2001/XMLSchema#string

Petar Jelinic

http://www.w3.org/2001/XMLSchema#string

Sasinya N Scott

http://www.w3.org/2001/XMLSchema#string

P2860

Fast and accurate short read alignment with Burrows-Wheeler transform

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

A framework for variation discovery and genotyping using next-generation DNA sequencing data

Integrative genomics viewer

High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing

Familial cluster of ovarian small cell carcinoma: a new mendelian entity?

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.

A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.

Detecting somatic genetic alterations in tumor specimens by exon capture and massively parallel sequencing.

P2888

P304

424-426

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3868621

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NG.2922

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P50

Robert A Soslow

Nikolaus Schultz

Jennifer J Mueller

Douglas A Levine

P577

2014-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1010985616

http://www.w3.org/2001/XMLSchema#string

P698

24658004

http://www.w3.org/2001/XMLSchema#string

P932

5699446

http://www.w3.org/2001/XMLSchema#string